BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10690855)

  • 1. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations.
    Seminara SB; Beranova M; Oliveira LM; Martin KA; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2000 Feb; 85(2):556-62. PubMed ID: 10690855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.
    Lavoie HB; Martin KA; Taylor E; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 1998 Jan; 83(1):241-7. PubMed ID: 9435449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone.
    Meysing AU; Kanasaki H; Bedecarrats GY; Acierno JS; Conn PM; Martin KA; Seminara SB; Hall JE; Crowley WF; Kaiser UB
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3189-98. PubMed ID: 15240592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration.
    Caron P; Chauvin S; Christin-Maitre S; Bennet A; Lahlou N; Counis R; Bouchard P; Kottler ML
    J Clin Endocrinol Metab; 1999 Mar; 84(3):990-6. PubMed ID: 10084584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred.
    de Roux N; Young J; Brailly-Tabard S; Misrahi M; Milgrom E; Schaison G
    J Clin Endocrinol Metab; 1999 Feb; 84(2):567-72. PubMed ID: 10022417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect.
    Kottler ML; Chauvin S; Lahlou N; Harris CE; Johnston CJ; Lagarde JP; Bouchard P; Farid NR; Counis R
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3002-8. PubMed ID: 10999776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production.
    Habiby RL; Boepple P; Nachtigall L; Sluss PM; Crowley WF; Jameson JL
    J Clin Invest; 1996 Aug; 98(4):1055-62. PubMed ID: 8770879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females.
    Seminara SB; Achermann JC; Genel M; Jameson JL; Crowley WF
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4501-9. PubMed ID: 10599709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.
    Costa EM; Bedecarrats GY; Mendonca BB; Arnhold IJ; Kaiser UB; Latronico AC
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2680-6. PubMed ID: 11397871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumors.
    Hall JE; Martin KA; Whitney HA; Landy H; Crowley WF
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1166-72. PubMed ID: 7962290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
    Santoro N; Wierman ME; Filicori M; Waldstreicher J; Crowley WF
    J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism.
    Blunt SM; Butt WR
    Acta Endocrinol Suppl (Copenh); 1988; 288():58-65. PubMed ID: 3138867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hypothalamic-pituitary-gonadal defect in a hypogonadic man with a novel mutation in the DAX-1 gene.
    Caron P; Imbeaud S; Bennet A; Plantavid M; Camerino G; Rochiccioli P
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3563-9. PubMed ID: 10522996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation.
    Reame NE; Sauder SE; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1985 Nov; 61(5):851-8. PubMed ID: 3900122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.